Literature DB >> 21063745

Intermittent high glucose promotes expression of proinflammatory cytokines in monocytes.

Yang Li-Bo1, Qi Wen-Bo, Lv Xiao-Hong, Feng You-Lun, Zhang Tie.   

Abstract

OBJECTIVE AND
DESIGN: The aim of this study was to examine expression of proinflammatory cytokines in monocytes under fluctuating glucose conditions. MATERIAL AND TREATMENT: Monocytic cells (THP-1) were divided into four groups and cultured in the presence of 5 or 15 mmol/L glucose or in fluctuating conditions (12 h exposure to 15 mmol/L glucose or mannitol medium followed by 12 h exposure to 5 mmol/L glucose or mannitol medium) respectively.
METHODS: Levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in the supernatants and surface expression of CD11b in monocytes were measured after 72 h culture. Paired Student's t tests were used to compare two groups and ANOVA for multiple comparisons.
RESULTS: Activation of monocytes was most pronounced in the fluctuating glucose conditions, as measured by concentrations of IL-6 and TNF-α in cultured supernatants and surface expression of CD11b in monocytes (P < 0.05). Fluctuating mannitol also induced a proinflammatory profile, but to a lesser extent than fluctuating glucose.
CONCLUSIONS: The results indicated that exposure to fluctuating glucose concentrations enhanced activation of monocytes compared with stable elevation of glucose concentrations. The effects were partly attributable to the inherent osmotic changes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21063745     DOI: 10.1007/s00011-010-0279-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  20 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

3.  Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta.

Authors:  Kosuke Azuma; Ryuzo Kawamori; Yukiko Toyofuku; Yoshiro Kitahara; Fumihiko Sato; Tomoaki Shimizu; Kyoko Miura; Tomoyuki Mine; Yasushi Tanaka; Masako Mitsumata; Hirotaka Watada
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-03       Impact factor: 8.311

4.  Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.

Authors:  S Devaraj; I Jialal
Journal:  Free Radic Biol Med       Date:  2000-10-15       Impact factor: 7.376

5.  Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro.

Authors:  T Kunt; T Forst; B Früh; T Flohr; S Schneider; O Harzer; A Pfützner; M Engelbach; M Löbig; J Beyer
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

6.  High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells.

Authors:  Narkunaraja Shanmugam; Marpadga A Reddy; Mausumee Guha; Rama Natarajan
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

7.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

8.  Hemoglobin A1c determination in the A1C-Derived Average Glucose (ADAG) study.

Authors:  Erna Lenters-Westra; Robbert J Slingerland
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

9.  TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide.

Authors:  B Kulseng; G Skjåk-Braek; I Følling; T Espevik
Journal:  Scand J Immunol       Date:  1996-03       Impact factor: 3.487

10.  Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.

Authors:  Itamar Raz; Peter W F Wilson; Krzysztof Strojek; Irina Kowalska; Velimir Bozikov; Anselm K Gitt; György Jermendy; Barbara N Campaigne; Lisa Kerr; Zvonko Milicevic; Scott J Jacober
Journal:  Diabetes Care       Date:  2009-03       Impact factor: 19.112

View more
  2 in total

Review 1.  Average daily risk range as a measure for clinical research and routine care.

Authors:  Susana R Patton; Mark A Clements
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

2.  Intermittent High Glucose Exacerbates A-FABP Activation and Inflammatory Response through TLR4-JNK Signaling in THP-1 Cells.

Authors:  Hui Li; Han-Ying Luo; Qing Liu; Yang Xiao; Lin Tang; Feng Zhong; Gan Huang; Jun-Mei Xu; Ai-Min Xu; Zhi-Guang Zhou; Ru-Ping Dai
Journal:  J Immunol Res       Date:  2018-04-11       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.